149 related articles for article (PubMed ID: 22736042)
1. Expression of FOXP1 in mucosa-associated lymphoid tissue lymphoma suggests a large tumor cell transformation and predicts a poorer prognosis in the positive thyroid patients.
Jiang W; Li L; Tang Y; Zhang WY; Liu WP; Li GD
Med Oncol; 2012 Dec; 29(5):3352-9. PubMed ID: 22736042
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
[TBL] [Abstract][Full Text] [Related]
3. Expression of PIK3CA and FOXP1 in gastric and intestinal non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue type.
Zhai L; Zhao Y; Ye S; Huang H; Tian Y; Wu Q; Lin H; Lin T
Tumour Biol; 2011 Oct; 32(5):913-20. PubMed ID: 21660567
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of miR-34a and its target proteins of FOXP1, p53, and BCL2 in gastric MALT lymphoma and DLBCL.
He M; Gao L; Zhang S; Tao L; Wang J; Yang J; Zhu M
Gastric Cancer; 2014; 17(3):431-41. PubMed ID: 24232982
[TBL] [Abstract][Full Text] [Related]
5. FOXP1 expression predicts polymorphic histology and poor prognosis in gastric mucosa-associated lymphoid tissue lymphomas.
Han SL; Wu XL; Wan L; Zeng QQ; Li JL; Liu Z
Dig Surg; 2009; 26(2):156-62. PubMed ID: 19365123
[TBL] [Abstract][Full Text] [Related]
6. C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas.
Huang W; Guo L; Liu H; Zheng B; Ying J; Lv N
Int J Clin Exp Pathol; 2014; 7(9):5634-44. PubMed ID: 25337204
[TBL] [Abstract][Full Text] [Related]
7. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control.
Goatly A; Bacon CM; Nakamura S; Ye H; Kim I; Brown PJ; Ruskoné-Fourmestraux A; Cervera P; Streubel B; Banham AH; Du MQ
Mod Pathol; 2008 Jul; 21(7):902-11. PubMed ID: 18487996
[TBL] [Abstract][Full Text] [Related]
8. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
[TBL] [Abstract][Full Text] [Related]
9. t(3;14)(p14.1;q32)/FOXP1-IGH translocation in thyroid extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Sasaki Y; Shiozawa E; Watanabe N; Homma M; Noh JY; Ito K; Takimoto M; Yamochi-Onizuka T
Leuk Res; 2020 Aug; 95():106399. PubMed ID: 32534365
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of FOXP1 in esophageal squamous cell carcinoma.
Wei Q; Li X; Zhu Z; Yu W; Qin G; Chen H; Gu Y; Zhao K; Fu X; Sun M
Pathol Res Pract; 2019 Dec; 215(12):152645. PubMed ID: 31704154
[TBL] [Abstract][Full Text] [Related]
12. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma.
Skacel M; Ross CW; Hsi ED
Histopathology; 2000 Jul; 37(1):10-8. PubMed ID: 10931213
[TBL] [Abstract][Full Text] [Related]
13. FOXP1 status in splenic marginal zone lymphoma: a fluorescence in situ hybridization and immunohistochemistry approach.
Baró C; Espinet B; Salido M; Colomo L; Luño E; Florensa L; Ferrer A; Salar A; Campo E; Serrano S; Solé F
Histol Histopathol; 2009 Nov; 24(11):1399-404. PubMed ID: 19760589
[TBL] [Abstract][Full Text] [Related]
14. Preferential expression of truncated isoforms of FOXP1 in primary central nervous system lymphoma.
Courts C; Brunn A; Montesinos-Rongen M; Siemer D; Hans V; Paulus W; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2009 Sep; 68(9):972-6. PubMed ID: 19680146
[TBL] [Abstract][Full Text] [Related]
15. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma.
Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD
Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173
[TBL] [Abstract][Full Text] [Related]
16. Prognostic markers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience.
Korać P; Dominis M
Croat Med J; 2008 Oct; 49(5):618-24. PubMed ID: 18925695
[TBL] [Abstract][Full Text] [Related]
17. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in the oromaxillofacial head and neck region: A retrospective analysis of 105 patients.
Zhang T; Wu Y; Ju H; Meng J; Guo W; Ren G
Cancer Med; 2020 Jan; 9(1):194-203. PubMed ID: 31733094
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation.
Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Banham AH; Ventura R; Matsumoto T; Iida M; Ohji Y; Yao T; Tsuneyoshi M; Du MQ
Gut; 2007 Oct; 56(10):1358-63. PubMed ID: 17525089
[TBL] [Abstract][Full Text] [Related]
19. Expression of FOXP1 and Colorectal Cancer Prognosis.
De Smedt L; Palmans S; Govaere O; Moisse M; Boeckx B; De Hertogh G; Prenen H; Van Cutsem E; Tejpar S; Tousseyn T; Sagaert X
Lab Med; 2015; 46(4):299-311. PubMed ID: 26489674
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
